Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Thomas

Showing results (301-310 of 333) with videos related to

Pageof 34
Sort By:
Intensive Care Medicine|July 2, 2022
Ventilatory settings in the initial 72 h and their association with outcome in out-of-hospital cardiac arrest patients: a preplanned secondary analysis of the targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest (TTM2) trialChiara Robba, Rafael Badenes, Denise Battaglini, et al.
Journal of Medicinal Chemistry|August 10, 2016
Optimization of Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for Duration of Action, as an Inhaled Therapy for Lung Remodeling in Pulmonary Arterial HypertensionDuncan E Shaw, Ferheen Baig, Ian Bruce, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of AsthmaDavid A Sandham, Lucy Barker, Lyndon Brown, et al.
Critical Care (London, England)|November 16, 2022
Speed of cooling after cardiac arrest in relation to the intervention effect: a sub-study from the TTM2-trialRupert F G Simpson, Josef Dankiewicz, Grigoris V Karamasis, et al.
Resuscitation|June 11, 2025
Radiological signs of hypoxic-ischaemic encephalopathy on head computed tomography for prediction of poor functional outcome after cardiac arrest - a prospective observational cohort studyMargareta Lang, Martin Kenda, Michael Scheel, et al.
Resuscitation Plus|June 9, 2022
Biomarkers of brain injury after cardiac arrest; a statistical analysis plan from the TTM2 trial biobank investigatorsMarion Moseby-Knappe, Helena Levin, Kaj Blennow, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Correction to "Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of Asthma"David A Sandham, Lucy Barker, Lyndon Brown, et al.
Nature|April 9, 2025
A non-contact wearable device for monitoring epidermal molecular fluxJaeho Shin, Joseph Woojin Song, Matthew Thomas Flavin, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 5, 2018
Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen's Inherited Cardiomyopathy Expert PanelMelissa A Kelly, Colleen Caleshu, Ana Morales, et al.
Resuscitation|December 9, 2024
Effects of very early hyperoxemia on neurologic outcome after out-of-hospital cardiac arrest: A secondary analysis of the TTM-2 trialFilippo Sanfilippo, Agnieszka Uryga, Cristina Santonocito, et al.
Pageof 34

Showing results (301-310 of 333) with videos related to

Sort By:
Pageof 34
Intensive Care Medicine|July 2, 2022
Ventilatory settings in the initial 72 h and their association with outcome in out-of-hospital cardiac arrest patients: a preplanned secondary analysis of the targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest (TTM2) trialChiara Robba, Rafael Badenes, Denise Battaglini, et al.
Journal of Medicinal Chemistry|August 10, 2016
Optimization of Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for Duration of Action, as an Inhaled Therapy for Lung Remodeling in Pulmonary Arterial HypertensionDuncan E Shaw, Ferheen Baig, Ian Bruce, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of AsthmaDavid A Sandham, Lucy Barker, Lyndon Brown, et al.
Critical Care (London, England)|November 16, 2022
Speed of cooling after cardiac arrest in relation to the intervention effect: a sub-study from the TTM2-trialRupert F G Simpson, Josef Dankiewicz, Grigoris V Karamasis, et al.
Resuscitation|June 11, 2025
Radiological signs of hypoxic-ischaemic encephalopathy on head computed tomography for prediction of poor functional outcome after cardiac arrest - a prospective observational cohort studyMargareta Lang, Martin Kenda, Michael Scheel, et al.
Resuscitation Plus|June 9, 2022
Biomarkers of brain injury after cardiac arrest; a statistical analysis plan from the TTM2 trial biobank investigatorsMarion Moseby-Knappe, Helena Levin, Kaj Blennow, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Correction to "Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of Asthma"David A Sandham, Lucy Barker, Lyndon Brown, et al.
Nature|April 9, 2025
A non-contact wearable device for monitoring epidermal molecular fluxJaeho Shin, Joseph Woojin Song, Matthew Thomas Flavin, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 5, 2018
Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen's Inherited Cardiomyopathy Expert PanelMelissa A Kelly, Colleen Caleshu, Ana Morales, et al.
Resuscitation|December 9, 2024
Effects of very early hyperoxemia on neurologic outcome after out-of-hospital cardiac arrest: A secondary analysis of the TTM-2 trialFilippo Sanfilippo, Agnieszka Uryga, Cristina Santonocito, et al.
Pageof 34